Dr. Sikora has 6 years of management and 12 years of biomedical research experience. His area of expertise is Corporate and Business Development. Dr. Sikora joined GenWay in 2006. Within a short period of time, he was able to establish business development related to GenWay’s proprietary IgY microbead technology, Seppro® system. He also established FirstMark Diagnostic Division at GenWay. He has taken the lead in forming partnerships, agreements and sales for GenWay’s custom services business, and he plays a key role in the development of the Company’s diagnostic FirstMark business. Dr. Sikora is also responsible for technology licensing.
Prior to joining GenWay, Dr. Sikora was a founder and Vice President of Business Development in MC-Fibers. During his tenure in MC-Fibers, he successfully established a customer base and developed the business strategy for the company. During his work at the Burnham Institute, Dr. Sikora developed a novel bioinformatics/experimental biology streamlining method for rapid experimental conformation of computational predictions, analyzed the SARS genome which resulted in a U.S. patent and published a number of research articles.
Dr. Sikora obtained his MBA degree from the Rady School of Management at the University of California, San Diego and his Ph.D. degree from UCLA. Dr. Sikora received his undergraduate degree in Biochemistry from UCLA with cum laude.
